{"id":"https://openalex.org/G7990429573","display_name":"HUMAN IPSC-DERIVED GABA-ERGIC PRECURSOR THERAPY FOR CHRONIC EPILEPSY","description":"HUMAN IPSC-DERIVED GABA-ERGIC PRECURSOR THERAPY FOR CHRONIC EPILEPSY","funder_award_id":"W81XWH1410558","funder":{"id":"https://openalex.org/F4320306078","display_name":"U.S. Department of Defense","doi":"https://doi.org/10.13039/100000005"},"funded_outputs":["https://openalex.org/W2211631996","https://openalex.org/W2901811281","https://openalex.org/W2904924273","https://openalex.org/W2905571427","https://openalex.org/W2944265914","https://openalex.org/W2976579447","https://openalex.org/W2981254749","https://openalex.org/W2981270226","https://openalex.org/W2992140359","https://openalex.org/W3108064720","https://openalex.org/W4289261284"],"funded_outputs_count":11,"parent_awards":[],"sub_awards":[],"sub_awards_count":0,"amount":908423.0,"currency":"USD","amount_usd":908423.0,"amount_usd_basis":"usd_native","recipients":[{"id":"https://openalex.org/I125029298","display_name":"Texas A&M Health Science Center","ror":"https://ror.org/01tx6pn92","country_code":"US","roles":["lead"],"share":null,"basis":"affiliation_matcher","asserted_by":"funder"}],"recipient_countries":[{"country_code":"US","share":1.0,"amount_usd":908423.0,"basis":"place_of_performance"}],"recipient_regions":[],"research_scope":{"is_research":true,"basis":"programme_rule","tier":2},"funding_type":"grant","funder_scheme":"MILITARY MEDICAL RESEARCH AND DEVELOPMENT","start_date":"2014-09-30","end_date":"2017-09-29","start_year":2014,"end_year":2017,"landing_page_url":"https://www.usaspending.gov/award/ASST_NON_W81XWH1410558_097/","doi":null,"provenance":"usaspending","lead_investigator":null,"co_lead_investigator":null,"investigators":null,"works_api_url":"https://api.openalex.org/works?filter=awards.id:G7990429573","primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9932,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9932,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10505","display_name":"Pluripotent Stem Cells Research","score":0.0011,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.001,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-epilepsy","display_name":"chronic epilepsy","score":0.884},{"id":"https://openalex.org/keywords/human-induced-pluripotent-stem-cells","display_name":"human induced pluripotent stem cells","score":0.884},{"id":"https://openalex.org/keywords/gabaergic-neurons","display_name":"GABAergic neurons","score":0.881},{"id":"https://openalex.org/keywords/cell-therapy","display_name":"cell therapy","score":0.449}],"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9858,"id":"https://metadata.un.org/sdg/3"}],"institution_awarded":[],"updated_date":"2026-11-13T03:01:57.000Z","created_date":"2026-08-06T15:05:35.000Z"}
